The Impact of DSM-5 on Psychiatric Clinical Trials: Challenges and Opportunities

A review of proposed DSM-5 criteria revisions and their implications for psychiatric trials

Read more

This brief review, featured in Journal for Clinical Studies, will summarize some of the more salient proposed revisions of the DSM-5 criteria, their implications for psychiatric trials, and resultant opportunities for psychiatric drug developers.


Chief Development Officer

Want to learn more about Worldwide Clinical Trials?